1. To explore what pharmacogenetics offers now and is likely to offer in the near future;
In particular to examine the effect of pharmacogenetics on:
a) the design of medicines, the promotion of efficacy and safety in the administration of medicines to individuals;
b) the conduct of clinical trials in the context of pharmaceutical research and development;
c) clinical practice.
2. To consider ethical issues specifically raised by pharmacogenetics;
In particular to examine the following areas:
a) consent, privacy and confidentiality;
b) the management of information about the likelihood of response to treatment;
c) the implications of differentiating individuals into groups based on the likelihodd of response to treatment.
3. To consider the implications for the provision of healthcare.